Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10650213 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL434916 | 1.00 | ALDH1A1 (0.50) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL19569859 | 0.88 | FAAH (0.54) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL10768725 | 0.84 | FAAH (0.59) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL5649671 | 0.83 | FAAH (0.35) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL783990 | 0.82 | SMN1; SMN2 (0.50) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL3145911 | 0.82 | SMN1; SMN2 (0.50) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL564562 | 0.82 | SMN1; SMN2 (0.50) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL9550539 | 0.82 | FAAH (0.66) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 | |
| SCHEMBL15602675 | 0.82 | FAAH (0.66) | ALDH1A1MAPTFAAHSMN1; SMN2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250152722-A1 | DRUG CONJUGATE OF GLUCOCORTICOID | SHANGHAI SENHUI MEDICINE CO., LTD. (CN) | 2025-05-15 | — | — | US | claimed |
| CN-119894535-A | Oritastatin derivatives and conjugates thereof | 祐方有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025067446-A1 | ANTIBODY-DRUG CONJUGATE TARGETING TROP2, AND PREPARATION METHOD AND USE THEREFOR | 信达生物制药(苏州)有限公司 | 2025-04-03 | — | — | WO | claimed |
| CN-119119176-A | Camptothecin derivatives | 伊缪诺金公司 | 2024-12-13 | — | — | CN | claimed |
| EP-4470569-A1 | DRUG CONJUGATE OF GLUCOCORTICOID | Shanghai Shengdi Pharmaceutical Co., Ltd (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-113766954-B | Camptothecin derivatives | 伊缪诺金公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118302199-A | Anti-CDH 6 antibodies and antibody-drug conjugates thereof | 普众发现医药科技(上海)有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2024140917-A1 | ANTI-CD40 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 上海盛迪医药有限公司 | 2024-07-04 | — | — | WO | claimed |
| EP-4374879-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE | Shanghai Senhui Medicine Co., Ltd. (CN) | 2024-05-29 | — | — | EP | claimed |
| US-20230144203-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2023-05-11 | — | — | US | claimed |
| EP-4094779-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | Shanghai Senhui Medicine Co., Ltd. (CN) | 2022-11-30 | — | — | EP | claimed |
| EP-2119372-A1 | Aroma compositions and preparations containing N-alpha-beta-alanyl-dipeptides | Symrise GmbH & Co. KG (DE) | 2009-11-18 | — | — | EP | claimed |
| US-5750555-A | NERVOUS SYSTEM DISORDERS; SKIN DISORDERS; IMMUNOLOGY | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1998-05-12 | — | — | US | claimed |
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2025-06-12 | — | — | US | disclosed |
| US-20250152722-A1 | DRUG CONJUGATE OF GLUCOCORTICOID | SHANGHAI SENHUI MEDICINE CO., LTD. (CN) | 2025-05-15 | — | — | US | disclosed |
| CN-119894535-A | Oritastatin derivatives and conjugates thereof | 祐方有限公司 | 2025-04-25 | — | — | CN | disclosed |
| EP-1971864-A2 | KIT COMPRISING 2,4-DICHLOROPHENOXYACETIC ACD DERIVATIVES AND ANTIBODIES FOR HIGHLY SENSITIVE DETECTION ASSAYS | Forschungszentrum Borstel (DE) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007051604-A2 | NOVEL 2,4-DICHLOROPHENOXY ACETIC ACID DERIVATIVES AND USE THEREOF IN DIAGNOSTIC AND ANALYTIC DETECTION METHODS | FORSCHUNGSZENTRUM BORSTEL (DE) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007051603-A2 | KIT COMPRISING 2, 4- DICHLOROPHENOXYACETIC ACD DERIVATIVES AND ANTIBODIES FOR HIGHLY SENSITIVE DETECTION ASSAYS | FORSCHUNGSZENTRUM BORSTEL (DE) | 2007-05-10 | — | — | WO | disclosed |
| US-5750555-A | NERVOUS SYSTEM DISORDERS; SKIN DISORDERS; IMMUNOLOGY | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1998-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188115-A1 | PROCESS FOR PREPARING A GLUCAGON-LIKE PEPTIDE | GLP1R, IAPP, GCG | ALDH1A1 4794/4885MAPT 4749/4885FAAH 1458/4885 |
| US-20250152722-A1 | DRUG CONJUGATE OF GLUCOCORTICOID | SHBG, CYP17A1, HSD17B7 | ALDH1A1 378/4885MAPT 4035/4885FAAH 2679/4885 |
| US-20230144203-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | ERLIN1, ERLIN2, EZR | ALDH1A1 493/4885MAPT 2162/4885FAAH 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.